Stone Warren 4

Accession 0001077183-25-000041

CIK 0001077183other

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:39 PM ET

Size

29.0 KB

Accession

0001077183-25-000041

Insider Transaction Report

Form 4

Period: 2025-02-21

NEOGENOMICS INCNEO

Stone Warren

Pres & Chief Operating Officer

Transactions

Tax Payment
Common Stock
2025-02-23−2,472→ 90,793 total
Exercise/Conversion
Restricted Stock Unit
2025-02-23−8,443→ 16,886 total
Exercise: $0.00→ Common Stock (8,443 underlying)
Exercise/Conversion
Common Stock
2025-02-23+8,443→ 93,265 total
Award
Stock Option (Right to Buy)
2025-02-21+143,266→ 143,266 total
Exercise: $13.05Exp: 2035-02-21→ Common Stock (143,266 underlying)
Award
Restricted Stock Unit
2025-02-21+84,317→ 84,317 total
Exercise: $0.00→ Common Stock (84,317 underlying)

Holdings

Restricted Stock Unit
Exercise: $0.00→ Common Stock (19,226 underlying)
19,226
Performance Stock Unit
Exercise: $0.00From: 2027-05-02→ Common Stock (17,908 underlying)
17,908
Restricted Stock Unit
Exercise: $0.00From: 2026-01-13→ Common Stock (59,382 underlying)
59,382
Performance Stock Unit
Exercise: $0.00From: 2026-05-11→ Common Stock (21,204 underlying)
21,204
Performance Stock Unit
Exercise: $0.00From: 2027-02-23→ Common Stock (25,330 underlying)
25,330
Stock Option (Right to Buy)
Exercise: $11.21Exp: 2029-12-01→ Common Stock (166,113 underlying)
166,113
Stock Option (Right to Buy)
Exercise: $16.45Exp: 2034-02-23→ Common Stock (42,344 underlying)
42,344
Restricted Stock Unit
Exercise: $0.00→ Common Stock (17,908 underlying)
17,908
Stock Option (Right to Buy)
Exercise: $19.65Exp: 2030-05-11→ Common Stock (53,969 underlying)
53,969
Stock Option (Right to Buy)
Exercise: $13.96Exp: 2034-05-02→ Common Stock (29,976 underlying)
29,976

Footnotes (16)

[F1]Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
[F10]On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
[F11]On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock overthe 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
[F12]On February 23, 2024, Mr. Stone was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F13]On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
[F14]On May 2, 2024, Mr. Stone was granted 29,976 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F15]On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
[F16]On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
[F2]Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
[F3]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
[F4]On February 21, 2025, Mr. Stone was granted 143,266 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F5]On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
[F6]Once vested, the shares of common stock are not subject to expiration.
[F7]On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
[F8]On December 1, 2022, Mr. Stone was granted 166,113 stock options. These options vest ratably over the first four anniversary dates of the grant date.
[F9]On May 11, 2023, Mr. Stone was granted 53,969 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Documents

1 file

4
wk-form4_1740519572.xmlPrimary
FORM 4

Issuer

NEOGENOMICS INC

CIK 0001077183

→

Entity typeother

Related Parties

filerCIK 0001955295

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 4:39 PM ET
Size: 29.0 KB

View on SEC.gov